When.com Web Search

  1. Ads

    related to: alternatives to statins to lower cholesterol and lose

Search results

  1. Results From The WOW.Com Content Network
  2. An alternative to statins may help reduce deaths from heart disease among people with high levels of LDL, or “bad” cholesterol, new research finds.. When taken as a daily pill, bempedoic acid ...

  3. The 40 Best Foods for Lowering Your Cholesterol, According to ...

    www.aol.com/40-best-foods-lowering-cholesterol...

    Adding these foods to your diet can help lower cholesterol, reduce plaque buildup in your arteries, and lower your risk of developing heart disease. The 40 Best Foods for Lowering Your Cholesterol ...

  4. Bempedoic acid vs. statins. Statins are drugs used to lower cholesterol, and they interfere with the production of cholesterol in your liver, according to Medline Plus. They specifically work to ...

  5. Portfolio diet - Wikipedia

    en.wikipedia.org/wiki/Portfolio_diet

    The Portfolio Diet is a therapeutic plant-based diet created by British researcher David J. Jenkins in 2003 to lower blood cholesterol. [1] [2] The diet emphasizes using a portfolio of foods or food components that have been found to associate with cholesterol lowering to enhance this effect.

  6. Bile acid sequestrant - Wikipedia

    en.wikipedia.org/wiki/Bile_acid_sequestrant

    They are occasionally used as an adjunct to the statins as an alternative to the fibrates (another major group of cholesterol-lowering drugs), which are thought to increase the risk of rhabdomyolysis when used with statins. The bile-acid-binding resins can raise triglycerides modestly (about 5%) and cannot be used if the triglycerides are elevated.

  7. Cholesterol absorption inhibitor - Wikipedia

    en.wikipedia.org/wiki/Cholesterol_absorption...

    Cholesterol absorption inhibitors are known to have a synergistic effect when combined a class of antihyperlipidemics called statins, to achieve an overall serum cholesterol target. For statin-resistant or statin-sensitive populations that are characterized by low one-year compliance rates, such a combination therapy is proving to be especially ...